폐기능과 요산 수치와의 관련성 = The Relationship between Pulmonary Function and Serum Uric Acid Level in the Korean Population

다국어 초록 (Multilingual Abstract)

Background: Forced vital capacity (FVC), forced expiratory volume in the first second (FEV1), and the ratio of FEV1 to FVC (FEV1/FVC) are considered as the major spirometry parameters. Serum uric acid is associated with increased risk of gout and cardiovascular disease. We analyzed the relationship between pulmonary function and serum uric acid level in the Korean men and women.
Methods: This study was based on the data collected during the 2016 Korea National Health and Nutrition Examination Survey (KNHANES VII-1). A total of 3,411 adults were retrieved from KNHANES VII-1. Among 3,411 adults, 1,500 were men and 1,911 were women.
Results: In this study, a significant negative correlation was observed between serum uric acid level and pulmonary function values only in females. Also, in the male non-smoker group, pulmonary function values were negatively associated with serum uric acid level (FVC %predicted, β=-0.014; FEV1 %predicted, β=-0.015).
Conclusions: In this study, hyperuricemia was associated with the low lung function in males and females. In order to obtain an accurate assessment of the association between hyperuricemia and pulmonary function values, further prospective cohort study in the future is necessary.

국문 초록 (Abstract)

연구배경: 강제폐활량과 1초간 강제호기량 등은 폐기능의지표로 측정된다. 또한 요산 수치는 통풍과 심혈관 질환의위험요인이다. 본 연구에서는 한국인 남성과 여성에서 폐기능과 요산 수치와의 관련성을 분석하였다.
방법: 연구 대상자는 2016년 국민건강영양조사에 참여한3,411명의 성인이다. 남성 1,500명, 여성 1,911명이 분석에포함되었다.
결과: 여성에서 폐기능과 요산 수치와의 음의 상관성을 보였다. 남성의 경우에는 비흡연자에서 폐기능과 요산과의 통계학적으로 유의한 음의 상관성이 있었다. 남성에서의 1초간 강제호기량이 낮은 사람은 1초간 강제호기량이 높은 사람들에 비해서 고요산혈증과 유의한 관련성이 있었다. 여성에서도 강제폐활량이 낮은 사람은 강제폐활량이 높은 사람들에 비하여 고요산혈증과 유의한 관련성이 있었다.
결론: 본 연구에서 고요산혈증은 남성과 여성 모두에서낮은 폐기능과 관련이 있었다. 인과관계를 더 정확히 알기위해서는 추후 전향적인 코호트 연구가 필요하겠다.

참고문헌 (Reference)

1 최정근, "한국인의 정상 폐활량 예측치" 대한결핵및호흡기학회 58 (58): 230-242, 2005

2 Marangella M, "Uric acid elimination in the urine. Pathophysiological implications" 147 : 132-148, 2005

3 Aida Y, "The relationship between serum uric acid and spirometric values in participants in a health check: the Takahata study" 8 (8): 470-478, 2011

4 B L, "The prevalence of hyperuricemia in China: a meta-analysis" 11 : 832-, 2011

5 Gan WQ, "The interactions between cigarette smoking and reduced lung function on systemic inflammation" 127 (127): 558-564, 2005

6 Fukuhara A, "The association between risk of airflow limitation and serum uric acid measured at medical health check-ups" 12 : 1213-1219, 2017

7 "Standardization of Spirometry, 1994 Update. American Thoracic Society" 152 (152): 1107-1136, 1995

8 Garcia-Pachon E, "Serum uric acid to creatinine ratio in patients with chronic obstructive pulmonary disease" 185 (185): 21-24, 2007

9 Durmus Kocak N, "Serum uric acid levels and uric acid/creatinine ratios in stable chronic obstructive pulmonary disease (COPD)patients: are these parameters efficient predictors of patients at risk for exacerbation and/or severity of disease?" 22 : 4169-4176, 2016

10 Song JU, "Serum uric acid is positively associated with pulmonary function in Korean health screening examinees" 27 (27): 1057-1065, 2017

11 Sarangi R, "Serum uric acid in chronic obstructive pulmonary disease: a hospital based case control study" 11 (11): BC09-BC13, 2017

12 Bartziokas K, "Serum uric acid as a predictor of mortality and future exacerbations of COPD" 43 (43): 43-53, 2014

13 Yoo TW, "Relationship between serum uric acid concentration and insulin resistance and metabolic syndrome" 69 (69): 928-933, 2005

14 Kim Y, "Prevalence of hyperuricemia and its associated factors in the general Korean population: an analysis of a population-based nationally representative sample" 37 (37): 2529-2538, 2018

15 Zhu Y, "Prevalence of gout and hyperuricemia in the US general population: the National Health and Nutrition Examination Survey 2007-2008" 63 (63): 3136-3141, 2011

16 Kim JW, "Prevalence and incidence of gout in Korea: data from the national health claims database 2007-2015" 37 (37): 1499-1506, 2017

17 Villegas R, "Prevalence and determinants of hyperuricemia in middle-aged, urban Chinese men" 8 (8): 263-270, 2010

18 Nicks ME, "Plasma antioxidants are associated with impaired lung function and COPD exacerbations in smokers" 8 (8): 264-269, 2011

19 Koran Centers for Disease Control and Prevention, "Korea National Health and Nutrition Examination Survey (KNHANES)" KCDC

20 Shibata Y, "Impact of reduced pulmonary function in the Japanese general population: lessons from the Yamagata-Takahata study" 57 (57): 220-226, 2019

21 Zhang X, "Hyperuricemia is a biomarker of early mortality in patients with chronic obstructive pulmonary disease" 10 : 2519-2523, 2015

22 Kim SY, "Hyperuricemia and coronary heart disease: a systematic review and meta-analysis" 62 (62): 170-180, 2010

23 Sung KC, "High sensitivity C-reactive protein as an independent risk factor for essential hypertension" 16 (16): 429-433, 2003

24 Mannino DM, "Global burden of COPD: risk factors, prevalence, and future trends" 370 (370): 765-773, 2007

25 Burchfiel CM, "Effects of smoking and smoking cessation on longitudinal decline in pulmonary function" 151 (151): 1778-1785, 1995

26 Bardin T, "Definition of hyperuricemia and gouty conditions" 26 (26): 186-191, 2014

27 Gan WQ, "Association between chronic obstructive pulmonary disease and systemic inflammation:a systematic review and a meta-analysis" 59 (59): 574-580, 2004

28 Barreiro TJ, "An approach to interpreting spirometry" 69 (69): 107-114, 2004